J&J lures Weber Shandwick exec to Janssen; Google healthcare head joins doc-networking firm M3; Novo Nordisk taps Hispanic marketing agency;

> Google's ($GOOG) former healthcare chief signed on to head up a new European division for the physician networking business M3, which operates Doctors.net.uk and MDLinx in Europe. Release

> Novo Nordisk ($NVO) hired New York-based Prime Access to handle its diabetes marketing and advertising targeted to the U.S. Hispanic community. Release

> Weber Shandwick's SVP of global marketing and corporate affairs, Jennifer Norton, is jumping ship to join Johnson & Johnson ($JNJ) as senior director of North American communications for Janssen. Report

> Closed loop marketing software provider Agnitio launched its latest product, Rainmaker, designed to personalize marketing to individual physicians. Release

> Lundbeck and Otsuka launched their once-monthly antipsychotic drug Abilify Maintena in Europe, with Denmark first to sign up for full reimbursement. Report

> Boehringer Ingelheim's first oncology product, the lung cancer treatment Giotrif, got a preliminary thumbs-up from U.K. cost-effectiveness gatekeepers. Report

> Ashfield Meetings & Events said it won a two-year extension to its contract to provide venue services for Bayer in the U.K. Report

And Finally... AbbVie ($ABBV) is supporting two educational initiatives in Latin America, including a new master's degree through Universidad Europa de Madrid, to improve rheumatology treatment. Report

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.